BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28658616)

  • 1. Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase.
    Emmanuel N; Ragunathan S; Shan Q; Wang F; Giannakou A; Huser N; Jin G; Myers J; Abraham RT; Unsal-Kacmaz K
    Cell Rep; 2017 Jun; 19(13):2665-2680. PubMed ID: 28658616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels.
    Hoxhaj G; Hughes-Hallett J; Timson RC; Ilagan E; Yuan M; Asara JM; Ben-Sahra I; Manning BD
    Cell Rep; 2017 Oct; 21(5):1331-1346. PubMed ID: 29091770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheb regulates nuclear mTORC1 activity independent of farnesylation.
    Zhong Y; Zhou X; Guan KL; Zhang J
    Cell Chem Biol; 2022 Jun; 29(6):1037-1045.e4. PubMed ID: 35294906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells.
    Peng H; Kasada A; Ueno M; Hoshii T; Tadokoro Y; Nomura N; Ito C; Takase Y; Vu HT; Kobayashi M; Xiao B; Worley PF; Hirao A
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1129-1135. PubMed ID: 29175333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination of Rheb governs growth factor-induced mTORC1 activation.
    Deng L; Chen L; Zhao L; Xu Y; Peng X; Wang X; Ding L; Jin J; Teng H; Wang Y; Pan W; Yu F; Liao L; Li L; Ge X; Wang P
    Cell Res; 2019 Feb; 29(2):136-150. PubMed ID: 30514904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays.
    Shams R; Ito Y; Miyatake H
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).
    Shibutani S; Okazaki H; Iwata H
    J Biol Chem; 2017 Nov; 292(44):18052-18061. PubMed ID: 28808055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid-Mediated Intracellular Ca
    Amemiya Y; Nakamura N; Ikeda N; Sugiyama R; Ishii C; Maki M; Shibata H; Takahara T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP70 interacts with Rheb, inhibiting mTORC1 signaling.
    Ryu HH; Ha SH
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1198-1203. PubMed ID: 33059920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation.
    Sato T; Mukai S; Ikeda H; Mishiro-Sato E; Akao K; Kobayashi T; Hino O; Shimono W; Shibagaki Y; Hattori S; Sekido Y
    Mol Cancer Res; 2021 May; 19(5):921-931. PubMed ID: 33574130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordination of Rheb lysosomal membrane interactions with mTORC1 activation.
    Angarola B; Ferguson SM
    F1000Res; 2020; 9():. PubMed ID: 32518628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheb localized on the Golgi membrane activates lysosome-localized mTORC1 at the Golgi-lysosome contact site.
    Hao F; Kondo K; Itoh T; Ikari S; Nada S; Okada M; Noda T
    J Cell Sci; 2018 Jan; 131(3):. PubMed ID: 29222112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment.
    Angarola B; Ferguson SM
    Mol Biol Cell; 2019 Oct; 30(22):2750-2760. PubMed ID: 31532697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.
    Kimoloi S
    Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.
    Yang H; Jiang X; Li B; Yang HJ; Miller M; Yang A; Dhar A; Pavletich NP
    Nature; 2017 Dec; 552(7685):368-373. PubMed ID: 29236692
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Fan TWM; Bruntz RC; Yang Y; Song H; Chernyavskaya Y; Deng P; Zhang Y; Shah PP; Beverly LJ; Qi Z; Mahan AL; Higashi RM; Dang CV; Lane AN
    J Biol Chem; 2019 Sep; 294(36):13464-13477. PubMed ID: 31337706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.
    Mahoney SJ; Narayan S; Molz L; Berstler LA; Kang SA; Vlasuk GP; Saiah E
    Nat Commun; 2018 Feb; 9(1):548. PubMed ID: 29416044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent Rheb-induced mTORC1 activation in spinal cord neurons induces hypersensitivity in neuropathic pain.
    Ma X; Du W; Wang W; Luo L; Huang M; Wang H; Lin R; Li Z; Shi H; Yuan T; Jiang W; Worley PF; Xu T
    Cell Death Dis; 2020 Sep; 11(9):747. PubMed ID: 32920594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling.
    Xie J; De Poi SP; Humphrey SJ; Hein LK; Bruning JB; Pan W; Selth LA; Sargeant TJ; Proud CG
    Cell Mol Life Sci; 2021 Apr; 78(8):4035-4052. PubMed ID: 33834258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR analysis of the backbone dynamics of the small GTPase Rheb and its interaction with the regulatory protein FKBP38.
    De Cicco M; Kiss L; Dames SA
    FEBS Lett; 2018 Jan; 592(1):130-146. PubMed ID: 29194576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.